STRUCTURALLY MODIFIED IKAV PEPTIDES AS BIOLOGICALLY ACTIVE LIGANDS IN TRIPLE-NEGATIVE BREAST CANCER
Hematology, Transfusion and Cell Therapy · 2026-03 · 48 · 106278
DOI: 10.1016/j.htct.2026.106278 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hematology, Transfusion and Cell Therapy, 2026-03. Verfasst von André Vinicius Zolesi und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação de Amparo à Pesquisa do Estado de São Paulo.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Fundação de Amparo à Pesquisa do Estado de São Paulo
Zitieren
APA
Zolesi, A. V., Sobral, D. V., Alves, F. L., Mendonça, F. F., Malavolta, L., & Fuscaldi, L. L. (2026). STRUCTURALLY MODIFIED IKAV PEPTIDES AS BIOLOGICALLY ACTIVE LIGANDS IN TRIPLE-NEGATIVE BREAST CANCER. Hematology, Transfusion and Cell Therapy, 48, 106278. https://doi.org/10.1016/j.htct.2026.106278
Vancouver
Zolesi AV, Sobral DV, Alves FL, Mendonça FF, Malavolta L, Fuscaldi LL. STRUCTURALLY MODIFIED IKAV PEPTIDES AS BIOLOGICALLY ACTIVE LIGANDS IN TRIPLE-NEGATIVE BREAST CANCER. Hematology, Transfusion and Cell Therapy. 2026;48:106278. doi:10.1016/j.htct.2026.106278
BibTeX
@article{Zolesi2026,
author = {Zolesi, André Vinicius and Sobral, Danielle Vieira and Alves, Flávio Lopes and Mendonça, Fernanda Ferreira and Malavolta, Luciana and Fuscaldi, Leonardo Lima},
title = {STRUCTURALLY MODIFIED IKAV PEPTIDES AS BIOLOGICALLY ACTIVE LIGANDS IN TRIPLE-NEGATIVE BREAST CANCER},
journal = {Hematology, Transfusion and Cell Therapy},
year = {2026},
volume = {48},
pages = {106278},
doi = {10.1016/j.htct.2026.106278}
}
EUVIMED